Elanco Animal Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-232	338	-1,231	-78	-483
Depreciation & Amortization	649	622	640	617	664
Other Amortization	31	40	54	65	52
Loss (Gain) From Sale of Assets	-	-640	-	-	-
Asset Writedown & Restructuring Costs	71	81	1,074	81	345
Stock-Based Compensation	68	55	46	59	66
Other Operating Activities	-126	-104	-12	170	-73
Change in Accounts Receivable	-12	12	-40	14	-35
Change in Inventory	-57	44	-160	-269	29
Change in Accounts Payable	147	82	-94	-98	-116
Change in Other Net Operating Assets	21	11	-6	-109	34
Operating Cash Flow	560	541	271	452	483
Operating Cash Flow Growth	3.51%	99.63%	-40.04%	-6.42%	-
Capital Expenditures	-276	-147	-140	-171	-159
Cash Acquisitions	-	-41	-19	-	-342
Divestitures	9	1,360	-	13	-
Sale (Purchase) of Intangibles	-	-	-	-13	-38
Other Investing Activities	-12	-14	-10	-8	9
Investing Cash Flow	-279	1,158	-169	-179	-530
Long-Term Debt Issued	2,646	570	600	988	1,064
Long-Term Debt Repaid	-2,919	-2,045	-677	-1,505	-823
Net Debt Issued (Repaid)	-273	-1,475	-77	-517	241
Other Financing Activities	-2	-17	-6	-32	-31
Financing Cash Flow	-275	-1,492	-83	-549	210
Foreign Exchange Rate Adjustments	71	-91	-12	-17	-31
Net Cash Flow	77	116	7	-293	132
Free Cash Flow	284	394	131	281	324
Free Cash Flow Growth	-27.92%	200.76%	-53.38%	-13.27%	-
Free Cash Flow Margin	6.02%	8.88%	2.97%	6.37%	6.80%
Free Cash Flow Per Share	0.57	0.79	0.27	0.57	0.67
Cash Interest Paid	-	-	-	266	221
Cash Income Tax Paid	-	140	95	93	151
Levered Free Cash Flow	559.75	941.38	395.13	316.13	792.5
Unlevered Free Cash Flow	712.88	1,108	573.88	466.75	940
Change in Working Capital	99	149	-300	-462	-88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.